Endogen Inc. said Monday that it has completed its move from Bostoninto a 21,000-square-foot facility in Cambridge, Mass., leased by theMassachusetts Institute of Technology. The company was previously ina facility about half that size.Endogen, which develops, manufactures and supplies biomedicalresearch products, said the move enables it to keep up with its growthand be closer to the Cambridge biotechnology community.

(c) 1997 American Health Consultants. All rights reserved.